Management of Severe Hyperglycemia (Blood Glucose 484 mg/dL)
A blood glucose of 484 mg/dL requires immediate assessment for life-threatening hyperglycemic emergencies (diabetic ketoacidosis or hyperosmolar hyperglycemic state), followed by aggressive insulin therapy with either intravenous insulin infusion if critically ill or subcutaneous basal-bolus insulin regimen if stable. 1, 2
Immediate Assessment (First Priority)
Check immediately for hyperglycemic crisis by assessing the following: 2
- Mental status changes (confusion, drowsiness, altered consciousness)
- Signs of dehydration (dry mucous membranes, poor skin turgor)
- Presence of nausea, vomiting, or abdominal pain
- Fruity breath odor (acetone smell indicating ketosis)
- Rapid, deep breathing (Kussmaul respirations)
Obtain urgent laboratory tests: 1, 2
- Serum or urine ketones
- Complete metabolic panel (electrolytes, renal function)
- Arterial blood gas if ketoacidosis suspected
- Calculate effective osmolality: 2[Na+ (mEq/L)] + glucose (mg/dL)/18 2
Critical Decision Point
If ANY of the following are present, this is a medical emergency requiring hospitalization: 3, 2
- Ketones present with vomiting or altered mental status (indicates diabetic ketoacidosis)
- Severe dehydration
- Altered level of consciousness
- Blood glucose ≥600 mg/dL (consider hyperosmolar hyperglycemic state)
Management for Hyperglycemic Crisis (If Present)
Initiate immediate fluid resuscitation with 0.9% sodium chloride at 15-20 mL/kg/hour during the first hour to restore circulatory volume. 2
Start continuous intravenous insulin infusion after excluding severe hypokalemia (K+ <3.3 mEq/L): 1, 2
- IV bolus of 0.1 units/kg
- Followed by continuous infusion at 0.1 units/kg/hour
- Target glucose range of 140-180 mg/dL 1
Monitor blood glucose every 30 minutes to 2 hours during IV insulin therapy to prevent hypoglycemia. 1
Management for Stable Severe Hyperglycemia (No Crisis)
For Blood Glucose 484 mg/dL Without Ketoacidosis
Initiate subcutaneous basal-bolus insulin regimen immediately as this level of hyperglycemia (>300 mg/dL) requires complex insulin therapy, not oral agents alone. 3, 1
Calculate total daily insulin dose at 0.3-0.5 units/kg body weight: 1
- Distribute as 50% basal insulin (long-acting)
- Distribute as 50% prandial insulin (rapid-acting, divided before meals)
Specific insulin regimen: 1
- Basal insulin: Start glargine or detemir at 0.2-0.25 units/kg once daily
- Prandial insulin: Add rapid-acting insulin (lispro, aspart, or glulisine) before meals at 0.1-0.15 units/kg divided into three doses
- Correction doses: Provide additional rapid-acting insulin for persistent hyperglycemia using a correction factor
Critical Pitfall to Avoid
Do NOT use sliding scale insulin alone without basal insulin - this approach is ineffective and strongly discouraged by guidelines. 1, 4
Transition from IV to Subcutaneous Insulin (If Hospitalized)
Administer basal insulin 2-4 hours BEFORE discontinuing IV insulin to prevent rebound hyperglycemia. 1
Transition only when: 1
- Patient is stable
- Glucose levels consistently below 200 mg/dL
- Patient able to eat
Monitoring Requirements
- Before each meal and at bedtime (minimum 4 times daily)
- Every 4-6 hours during acute illness 2
- More frequently if adjusting insulin doses
Adjust insulin doses daily based on blood glucose patterns until stable control achieved. 1
Identify and Address Underlying Cause
Common causes of severe hyperglycemia requiring investigation: 2
- Missed or inadequate insulin doses
- New diagnosis of diabetes
- Intercurrent illness or infection
- Corticosteroid use
- Medication non-compliance
Ensure adequate fluid and caloric intake to prevent dehydration and electrolyte imbalances. 3, 2
When to Seek Immediate Medical Attention
Call emergency services or go to emergency department if: 3, 2
- Blood glucose remains >300 mg/dL over 2 consecutive days despite treatment
- Any symptoms of ketoacidosis develop (vomiting, abdominal pain, fruity breath, confusion)
- Unable to keep fluids down
- Persistent symptoms of severe hyperglycemia (excessive thirst, frequent urination, weakness)
Long-Term Management After Stabilization
Add metformin as first-line oral therapy (if renal function normal) once acute hyperglycemia controlled to prevent recurrence. 1, 2
Continue insulin therapy long-term if HbA1c >10% or if patient was severely insulin-deficient at presentation. 1
Schedule follow-up within 1-2 weeks to reassess glycemic control and adjust regimen. 1, 2
Provide diabetes self-management education including sick-day management and recognition of hyperglycemic symptoms. 1, 2
Important Safety Considerations
Monitor closely for hypoglycemia during insulin therapy - patients should always carry quick-acting sugar (hard candy or glucose tablets). 5
Never discontinue insulin during illness - insulin requirements may actually increase during stress or infection. 2, 5
Increase monitoring frequency to every 4-6 hours during any acute illness, infection, or stressful situation. 2, 5